메뉴 건너뛰기




Volumn 5, Issue 7, 2010, Pages 1282-1289

The CLEAR study: A 5-day, 3-g loading dose of mycophenolate Mofetil versus standard 2-g dosing in renal transplantation

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

EID: 77954764816     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09091209     Document Type: Article
Times cited : (48)

References (20)
  • 1
    • 0031024728 scopus 로고    scopus 로고
    • Mycophenolate mofetil in renal allograft recipients: A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection
    • The International Mycophenolate Mofetil Renal Transplant Study Groups
    • Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C: Mycophenolate mofetil in renal allograft recipients: A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. Transplantation 63: 39-47, 1997
    • (1997) Transplantation , vol.63 , pp. 39-47
    • Halloran, P.1    Mathew, T.2    Tomlanovich, S.3    Groth, C.4    Hooftman, L.5    Barker, C.6
  • 3
    • 27644540081 scopus 로고    scopus 로고
    • The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation
    • Srinivas TR, Kaplan B, Schold JD, Meier-Kriesche HU: The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation. Transplantation 80: S211-S220, 2005
    • (2005) Transplantation , vol.80
    • Srinivas, T.R.1    Kaplan, B.2    Schold, J.D.3    Meier-Kriesche, H.U.4
  • 4
    • 65549153182 scopus 로고    scopus 로고
    • Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: A systematic review
    • Knight SR, Russell NK, Barcena L: Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: A systematic review. Transplantation 87: 785-794, 2009
    • (2009) Transplantation , vol.87 , pp. 785-794
    • Knight, S.R.1    Russell, N.K.2    Barcena, L.3
  • 5
    • 0038246498 scopus 로고    scopus 로고
    • Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies
    • DOI 10.1034/j.1600-6143.2003.00079.x
    • Shaw LM, Korecka M, Venkataramanan R, Goldberg L, Bloom R, Brayman KL: Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies. Am J Transplant 3: 534-542, 2003 (Pubitemid 36612836)
    • (2003) American Journal of Transplantation , vol.3 , Issue.5 , pp. 534-542
    • Shaw, L.M.1    Korecka, M.2    Venkataramanan, R.3    Goldberg, L.4    Bloom, R.5    Brayman, K.L.6
  • 9
    • 3042743984 scopus 로고    scopus 로고
    • Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation
    • DOI 10.1111/j.1600-6143.2004.00455.x
    • Kiberd BA, Lawen J, Fraser AD, Keough-Ryan T, Belitsky P: Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation. Am J Transplant 4: 1079-1083, 2004 (Pubitemid 38868597)
    • (2004) American Journal of Transplantation , vol.4 , Issue.7 , pp. 1079-1083
    • Kiberd, B.A.1    Lawen, J.2    Fraser, A.D.3    Keough-Ryan, T.4    Belitsky, P.5
  • 10
    • 21844466718 scopus 로고    scopus 로고
    • Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant period
    • DOI 10.1016/j.transproceed.2005.03.059, PII S0041134505002976
    • Kiberd BA, Puthenparumpil JJ, Fraser A, Tett SE, Lawen J: Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant period. Transplant Proc 37: 2320-2323, 2005 (Pubitemid 40956441)
    • (2005) Transplantation Proceedings , vol.37 , Issue.5 , pp. 2320-2323
    • Kiberd, B.A.1    Puthenparumpil, J.J.2    Fraser, A.3    Tett, S.E.4    Lawen, J.5
  • 11
    • 0036721306 scopus 로고    scopus 로고
    • Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus
    • Pawinski T, Hale M, Korecka M, Fitzsimmons WE, Shaw LM: Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus. Clin Chem 48: 1497-1504, 2002 (Pubitemid 34925784)
    • (2002) Clinical Chemistry , vol.48 , Issue.9 , pp. 1497-1504
    • Pawinski, T.1    Hale, M.2    Korecka, M.3    Fitzsimmons, W.E.4    Shaw, L.M.5
  • 13
    • 0016916438 scopus 로고
    • Prediction of creatinine clearance from serum creatinine
    • Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41, 1976
    • (1976) Nephron , vol.16 , pp. 31-41
    • Cockcroft, D.W.1    Gault, M.H.2
  • 14
    • 0031786415 scopus 로고    scopus 로고
    • Evaluation of an immunoassay (EMIT) for mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatography assay
    • Beal JL, Jones CE, Taylor PJ, Tett SE: Evaluation of an immunoassay (EMIT) for mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatography assay. Ther Drug Monit 20: 685-690, 1998
    • (1998) Ther Drug Monit , vol.20 , pp. 685-690
    • Beal, J.L.1    Jones, C.E.2    Taylor, P.J.3    Tett, S.E.4
  • 15
    • 33645450634 scopus 로고    scopus 로고
    • Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: A population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients
    • van Hest RM, Mathot RA, Pescovitz MD, Gordon R, Mamelok RD, van Gelder T: Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: A population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients. J Am Soc Nephrol 17: 871-880, 2006
    • (2006) J Am Soc Nephrol , vol.17 , pp. 871-880
    • Van Hest, R.M.1    Mathot, R.A.2    Pescovitz, M.D.3    Gordon, R.4    Mamelok, R.D.5    Van Gelder, T.6
  • 17
    • 2042515610 scopus 로고    scopus 로고
    • Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients
    • DOI 10.1016/j.clpt.2003.12.009, PII S0009923603007707
    • Kuypers DR, Claes K, Evenepoel P, Maes B, Vanrenterghem Y: Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients. Clin Pharmacol Ther 75: 434-447, 2004 (Pubitemid 38534564)
    • (2004) Clinical Pharmacology and Therapeutics , vol.75 , Issue.5 , pp. 434-447
    • Kuypers, D.R.J.1    Claes, K.2    Evenepoel, P.3    Maes, B.4    Vanrenterghem, Y.5
  • 20
    • 0742322211 scopus 로고    scopus 로고
    • Interleukin 2 receptor antagonists for renal transplantation recipients: A meta-analysis of randomized trials
    • DOI 10.1097/01.TP.0000109643.32659.C4
    • Webster AC, Playford EG, Higgins G, Chapman JR, Craig JC: Interleukin 2 receptor antagonists for renal transplant recipients: A meta-analysis of randomized trials. Transplantation 77: 166-176, 2004 (Pubitemid 38155741)
    • (2004) Transplantation , vol.77 , Issue.2 , pp. 166-176
    • Webster, A.C.1    Playford, E.G.2    Higgins, G.3    Chapman, J.R.4    Craig, J.C.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.